Variant report
Variant | nsv889944 |
---|---|
Chromosome Location | chr8:4114456-4131490 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs563448517 | chr8:4119812-4119813 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs575554998 | chr8:4119822-4119823 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs184247835 | chr8:4119830-4119831 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs560827673 | chr8:4119859-4119860 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs6986522 | chr8:4119868-4119869 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs546299443 | chr8:4119877-4119878 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs565203403 | chr8:4119881-4119882 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs145632641 | chr8:4119887-4119888 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs138250642 | chr8:4119893-4119894 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs569100226 | chr8:4119897-4119898 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs570665107 | chr8:4119906-4119907 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs536456647 | chr8:4119938-4119939 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs113365892 | chr8:4119968-4119969 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs547220750 | chr8:4119970-4119971 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs560839074 | chr8:4119977-4119978 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs566876869 | chr8:4119984-4119985 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs188492619 | chr8:4119989-4119990 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs142834824 | chr8:4119994-4119995 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs577335130 | chr8:4119997-4119998 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs537911886 | chr8:4120015-4120016 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs146082622 | chr8:4120029-4120030 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs557331006 | chr8:4120047-4120048 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs779105 | chr8:4120070-4120071 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs148747268 | chr8:4120075-4120076 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs141234114 | chr8:4120091-4120092 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs572868008 | chr8:4120107-4120108 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs540351002 | chr8:4120122-4120123 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs564536912 | chr8:4120128-4120129 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs1394485 | chr8:4120154-4120155 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs180909129 | chr8:4120158-4120159 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs569251483 | chr8:4120162-4120163 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs562847973 | chr8:4120169-4120170 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs530288415 | chr8:4120174-4120175 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs150784780 | chr8:4120195-4120196 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs542221480 | chr8:4128008-4128009 | Active TSS Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs560330041 | chr8:4128012-4128013 | Active TSS Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs528378217 | chr8:4128030-4128031 | Active TSS Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs546589398 | chr8:4128039-4128040 | Active TSS Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs571374486 | chr8:4128064-4128065 | Active TSS Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs371518415 | chr8:4128083-4128084 | Active TSS Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs548119552 | chr8:4128109-4128110 | Active TSS Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs190464289 | chr8:4128129-4128130 | Active TSS Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs710256 | chr8:4128143-4128144 | Active TSS Bivalent Enhancer Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs138541904 | chr8:4128146-4128147 | Active TSS Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs141556920 | chr8:4128150-4128151 | Active TSS Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs568383596 | chr8:4128160-4128161 | Active TSS Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs554548412 | chr8:4128166-4128167 | Active TSS Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs369174154 | chr8:4128170-4128171 | Active TSS Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs181841740 | chr8:4128176-4128177 | Active TSS Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs146203183 | chr8:4128183-4128184 | Active TSS Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 16573809 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
abnormal development | 18461090 | CNVD |
Crohn''s disease | 19220326 | CNVD |
Psoriasis | 19220326 | CNVD |
Prostate cancer | 21965145 | CNVD |
Prostate cancer | 18515986 | CNVD |
Chronic obstructive pulmonary disease | 20378733 | CNVD |
Autism | 18414403 | CNVD |
Cancer | 21183584 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Breast cancer | 17603634 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Cervical cancer | 17311676 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Schizophrenia | 20877625 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 17001317 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Heart disease | 21282601 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Breast cancer | 17393978 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Breast cancer | 20837533 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 22429812 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21264507 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 21088497 | CNVD |
Breast cancer | 20940404 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Gastric cancer | 17167181 | CNVD |
Prostate cancer | 16705090 | CNVD |
8p-syndrome | 17576883 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Prostate cancer | 17245344 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Cancer | 16751803 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Breast cancer | 21785460 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Breast cancer | 21509527 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Epilepsy | 22083797 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Congenital diaphragmatic hernia | 21064195 | CNVD |
Breast cancer | 21364760 | CNVD |
Cancer | 20164920 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Prostate cancer | 17217626 | CNVD |
Developmental delay | 19128483 | CNVD |
Neuroticism | 17667963 | CNVD |
Leukoplakia | 24403051 | CNVD |
Intellectual disability | 22045946 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16608533 | CNVD |
Seminomas | 18059402 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Colorectal cancer | 22014273 | CNVD |
Lung squamous cell carcinoma | 22363434 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Cancer | 20164919 | CNVD |
Non-syndromic sensorineural hearing loss | 17289997 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Tetralogy of Fallot | 22912587 | CNVD |
Schizophrenia | 21346763 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:4119800-4120200 | Enhancers | Primary monocytes fromperipheralblood | blood |
2 | chr8:4119800-4120200 | Enhancers | Dnd41 | blood |
3 | chr8:4128000-4128400 | Active TSS | Duodenum Mucosa | Duodenum |
4 | chr8:4128000-4128400 | Enhancers | Fetal Intestine Small | intestine |
5 | chr8:4128000-4128400 | Active TSS | Rectal Mucosa Donor 29 | rectum |
6 | chr8:4128000-4132600 | Bivalent Enhancer | Fetal Heart | heart |